Skip to main content

Madison (US) facility

Our team specializes in pharmaceutical development as well as crop production and chemical development. Madison offers you the unique ability to support all aspects of human, AME, flow cytometry and bioanalysis on one campus, so your studies run smoothly and efficiently.

1M+ Gross Ft2
330+ No. of Study Rooms
60+ No. of PhDs
1,500+ Total Employment
cgt-feature
NEW CELL AND GENE THERAPY SUITE

A macro investment in micro science

Cell and gene therapies are incredibly intricate, but they’re making a huge difference in the drug development market and in the lives of patients. Learn all about our $9.2 million investment in cell and gene therapy.

MAKING YOUR BREAKTHROUGHS POSSIBLE

Our major commitment to your Early Development studies

Over the past five years, we’ve invested more than $700 million in nonclinical development to enhance our capabilities for your programs. From expanded lab space in our U.S., European and Asia Pacific sites to state-of-the-art instrumentation and digitized workflows, we’ve innovated where it matters most to empower your healthcare mission.

SparC of Innovation magazine

Key capabilities

Qualifications

  • Animal housing compliant with the Guide to the Care and Use of Laboratory Animals, 8th edition
  • AAALAC accredited

Dose Routes

  • Bladder
  • Cannula
  • Dermal
  • Inhalation
  • Implant
  • Intraarticular
  • Intracecal
  • Intracisternal
  • Intradermal
  • Intrajejunal
  • Intramuscular
  • Intranasal
  • Intraperitoneal
  • Intrathecal
  • Intrauterine
  • Intravesicular
  • Intraventricular
  • IV: bolus, continuous infusion, intermittent infusion
  • MRI guided
  • Ocular: intervitreal, intracameral, subretinal, topical
  • Oral: capsule, diet, gavage
  • Otic
  • Subcutaneous
  • Sublingual

Let's start a conversation